Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Gustav Graff"'
Autor:
Thomas R. Dean, Gustav Graff, Mark R. Hellberg, Tai-Lee Ke, Peter G. Klimko, Karen S. Haggard
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 19:97-103
Bimatoprost (Lumigan), the ethyl amide derivative of the potent prostaglandin FP agonist 17-phenyl-trinor PGF(2alpha), has been reported to be a member of a pharmacologically unique class of ocular hypotensive agents. To confirm that bimatoprost, whi
Autor:
Steven T. Miller, Howard L. Brockman, John M. Yanni, Gustav Graff, Maureen M. Momsen, Joshua R. Knudtson
Publikováno v:
Ocular Immunology and Inflammation. 11:247-268
Olopatadine, an effective topical ocular human conjunctival mast cell stabilizer/antihistaminic antiallergic drug, was evaluated and compared to selected classical antihistamines for their interaction with model and natural membranes to ascertain pot
Autor:
Lori K. Weimer, Mark R. Hellberg, Karen C. David, Jon C. Nixon, Gustav Graff, Milton T. Brady
Publikováno v:
Inflammation. 27:31-43
Selected ester- (AL-5898 and AL-8417) and amide-linked benzopyran analogues (AL-7538 and AL-12615) were evaluated in vitro for their ability to inhibit key enzymes/processes of the inflammatory response. AL-7538 and AL-12615 exhibited weak intrinsic
Autor:
Sally A. Scheib, William H. Garner, Bruce A. Berkowitz, Gustav Graff, Charles A. Wilson, Mizuto Suzuki
Publikováno v:
Current Eye Research. 23:372-381
Purpose. To compare ocular vascular permeability in the rabbit after vitrectomy as assessed by contrast-enhanced magnetic imaging (CE-MRI) and measurements of aqueous and vitreous humor protein concentration. Methods. Partial vitrectomies were perfor
Publikováno v:
Acta Ophthalmologica Scandinavica. 78:10-15
Olopatadine is a human conjunctival mast cell stabilizer with antihistaminic activity. Ketotifen is an older molecule that possesses antihistaminic activity and is reported to have additional pharmacological properties. The interactions of these two
Publikováno v:
Inflammation. 24:357-370
Nepafenac, the amide analog of 2-amino-3-benzoylbenzeneacetic acid (amfenac), was examined in preclinical models for its potential utility as a topical ocular anti-inflammatory agent. Diclofenac was selected as the reference compound. In contrast to
Publikováno v:
Inflammation. 24:371-384
Nepafenac, the amide analog of the NSAID amfenac, was examined in vitro for its bioactivation by ocular tissue components and its ability to permeate external ocular barriers. Rabbit tissues catalyzed a concentration-dependent conversion of nepafenac
Autor:
Joan M. Spellman, Gustav Graff, S. Dan Dimitrijevich, Laura Smith Lang, Lori K. Weimer, John M. Yanni, Daniel A. Gamache
Publikováno v:
Ocular Immunology and Inflammation. 5:117-128
The production of cytokines by human conjunctival epithelial cells following stimulation was investigated. Primary cultures of human conjunctival epithelial cells were characterized by morphology and keratin expression. Cultured epithelial cells were
Autor:
Gustav Graff, Joan M. Spellman, L S Lang, D.W. Parnell, Lori K. Weimer, Steven T. Miller, Milton T. Brady, D.J. Stephens, John M. Yanni, Daniel A. Gamache
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 12:389-400
Olopatadine (AL-4943A; KW-4679) [(z)-11-[3-(dimethylamino)propylidene]-6, 11-dihydrodibenz[b,e]oxepine-2 acetic acid hydrochloride] is an anti-allergic agent which inhibits mast cell mediator release and possesses histamine H1 receptor antagonist act
Autor:
Joseph C. Nolan, David A. Walsh, L. F. Sancilio, W. J. Jun. Welstead, Gustav Graff, Dwight A. Shamblee, Henry W. Moran
Publikováno v:
ChemInform. 22